CF

Chase Feiger

Ostro

United States

Invests in

Stages:

Sectors:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Entrepreneurship
Strategy
Venture Capital
Business Strategy
Consulting
Fundraising
Product Development
Public Health
Leadership
Information Technology
Mergers & Acquisitions
Healthcare Information Technology
Business Intelligence
Due Diligence
Educational Technology
Start-ups
Strategic Planning
Management Consulting
Management
Business Development

Education

Work Experience

2019

  • Co-Founder

    2019

    Ostro is an AI company offering the first end-to-end solution for digital commercialization in the life sciences sector. We are a team of former Google, Amazon, McKinsey, Hims & Hers, Abbvie, Doximity engineers, life scientists, doctors, designers and product innovators to digitize and provide next-generation software solutions for HCPs, consumers, and life science companies. www.ostrohealth.com

2018

  • Contributing Writer

    2018

    Contributing writer for Forbes, focusing primarily on life sciences. I've written a number of pieces covering areas such as the enterprise tech, consumer tech, consumerization of healthcare, medical device manufacturing, and pharma manufacturing.

  • Venture Partner

    2021

2023 - 2024

  • Sequoia Scout

    2023 - 2024

    Investing in pre-seed and seed stage AI, Enterprise, Health Tech, and Life Science Software companies

  • Adjunct Lecturer

    2020 - 2024

    Teaching a course entitled "Disruption and Innovation in the Healthcare Market"

2013 - 2018

  • Co-Founder

    2013 - 2018

    Parsable (formerly known as Wearable Intelligence from 2013-2015) is an enterprise SaaS company, transforming the lives, productivity, and safety for the 70% of the global workforce whose jobs aren’t performed at a desk, and making measurable impact to billion-dollar problems affecting the world’s global industries (often ignored by Silicon Valley). We’ve built mobile-first software for collaboratively completing process-based work that is already in use at global Fortune 500 companies across a variety of industries such as industrial manufacturing, aerospace/defense manufacturing, energy, CPG manufacturing, medical device manufacturing, pharmaceutical manufacturing, and more. With it, teams can author and execute complex procedures, collaborate in real-time with team members and across the supply chain, and for the first time have hands-on access to everything they need to get the job done right, anywhere and on any device. Parsable powers $1 trillion in production revenue for industrial operations: -360,000+ monthly jobs completed -deployed in 80+ countries around the world with 20+ languages supported -75% reduced defects -12% increased throughput -10% decreased waste -6% improved OEE Along with my two cofounders, we pivoted the company three times from 2013-2015 ultimately finding product-market fit in August 2015 through extensive customer development across 10+ industry sectors. Scaled the company from $0-$XXM ARR SaaS/$XXXM enterprise value in 2018, before leaving the company to finish my clinical rotations in medical school.

2013 - 2018

  • Partner

    2013 - 2018

    An operator fund with investments in: Masterclass.com (Series A, B, and C) Thumbtack (Seed, Series A, Series B, Series C) Dynasty.com (Seed) (acq. by NASDAQ: APPF) Rocksbox.com (Seed) (acq. by NYSE:SIG) Howdy.ai/XOXCO (Seed) (acq. by NASDAQ: MSFT) Buddybuild (Seed) (acq. by NASDAQ: AAPL) Mixer Labs (Seed) (acq. by NYSE: TWTR)

  • Intern

    2012 - 2013

    -While in medical school, I provided research and insight to existing portfolio companies -Helped conduct due diligence on new potential investments -Left to start Parsable, which First Round Capital led the seed round for.

2011 - 2012

  • Strategy Consultant

    2011 - 2012

    -Immediately following my graduation from UPenn, I worked as a full-time strategy consultant at Accenture, focusing on Energy, Chemicals, Pharmaceuticals and Health IT -I left Accenture after being awarded a Trust Scholarship to attend Cambridge University for my Masters

  • Research Coordinator

    2007 - 2010

    August 2010-December 2010 Studied the use of health information technology changes in workflow engendered by clinician (RN) respondents and (MD) respondents September 2009-January 2010 Conducted organizational behavior research in the Neuro ICU, studying how workflow is affected by architecture and health information technologies. Using this research, I co-authored multiple papers November 2007-May 2009 Worked as a research coordinator in the Department of Cardiothoracic Surgery. Most of my work was completed through the IRAD Database Worked in these roles as an undergrad at UPenn. Left in 2010 since I graduated.